The type I (EGFR-related) involved in the biological behavior of breast cancer cells is HER2 growth factor receptor, which gene is overexpressed in about 15–20% of breast cancers and represents a worse prognosis (Perez et al., 2013). This evidence concerns the gene EGFR and breast carcinoma.